Well, the fact he sent it to you means its in the public domain ... so I see no problem. After all, if it was in anyway contraveneing market regs he wouldn't have sent it to you.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025